Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Breast Neoplasms 704Neoplasms 621Prostatic Neoplasms 319Lung Neoplasms 314Colorectal Neoplasms 284Carcinoma, Non-Small-Cell Lung 257Pancreatic Neoplasms 181Carcinoma, Hepatocellular 172Stomach Neoplasms 141Multiple Myeloma 128Ovarian Neoplasms 123Melanoma 118Colonic Neoplasms 114Brain Neoplasms 111Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 104Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 91Liver Neoplasms 91Neoplasm Metastasis 90Lymphoma 86Rectal Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Endometrial Neoplasms 79Carcinoma, Renal Cell 74Leukemia 65Recurrence 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Sturge-Weber Syndrome × 1 year × Clear all
NCT01425944 2026-03-02

Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Active not recruiting
600 enrolled

Sturge-Weber Syndrome

NCT07327164 2026-01-09

Precision Medicine for Neurocutaneous Syndromes in Western China

West China Hospital

Completed
1,200 enrolled
CNSDermatologic

von Hippel-Lindau Disease, Neurofibromatosis 1, Sturge-Weber Syndrome, Tuberous Sclerosis, Neurocutaneous Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡